BayWa Restructuring Advances Under Court Oversight, Stakes Rise on Autumn Milestones

BayWa appoints new supervisory board, slashes deal limit to €50M. Rescue hinges on 2025 audit, standstill extension, T&G sale; creditors push for €1B debt haircut.

A court-ordered refresh of BayWa’s supervisory board arrives just as the group faces a tightening set of conditions for its rescue plan, with three autumn milestones looming large. The court appointed Dr. Ines Kapphan, Solveig Menard-Galli and Christine Rittner-Koch to the Aufsichtsrat, to be confirmed by shareholders at the next general meeting. At the same time, BayWa is making a sweeping change to its internal governance: the previous limit allowing the board to execute deals up to €200 million without supervisory oversight has been slashed to €50 million. The move signals a tighter grip on risk as the restructuring unfolds.

The timing could hardly be more delicate. BayWa’s 2025 annual financial statements will not be finalized until the end of 2026—a pronounced delay that has traders reading the situation as an indicator of the complexity surrounding the turnaround. The company continues to pursue a multi-year restructuring target of €4 billion by 2028, of which €1.3 billion has been secured so far. Management notes that liquidity has reached the highest level since the crisis began, though a formal operational confirmation remains pending.

From a market perspective, the chart remains bruised. BayWa’s shares closed at €12.95 on Friday, trading near multi-year lows and down about 23% year-to-date. The RSI sits at 58.7 points, a neutral reading, while the gap to the 200-day moving average sits at roughly 20%, underscoring the persistent downtrend. In the near term, the €13 handle acts as a first resistance; a sustained move above the 20-day moving average could offer some stabilization, but uncertainty around debt servicing leaves the stock vulnerable to ongoing volatility.

Looking ahead, investors will scrutinize next week’s quarterly update for Q1 2026, with particular attention on net debt levels and progress on planned asset sales. One focal point remains T&G Global, the New Zealand fruit operation BayWa has targeted for disposition. Complex shareholder structures could complicate negotiations as the group weighs strategic options.

The path to completion rests on three autumn tasks, a triad that BayWa itself frames as non-negotiable: deliver the tested annual report for 2025, extend the standstill agreement with its creditor banks, and push forward the sale of T&G Global. If any element stalls, the entire restructuring framework could lose its footing.

The old rescue blueprint—the sale of 51% of the energy subsidiary BayWa r.e.—has effectively collapsed. The expected €1.7 billion windfall is no longer on the table, as losses from U.S. subsidies to renewable projects have eroded value. In its place, a fresh concept is slated for mid-2026, likely centering on a debt haircut that would require creditors to forgo roughly €1 billion. The stalemate among lenders is sharp: DZ Bank and UniCredit are pressing for haircuts, seniority protections, and a long dividend pause. The strength of the position among creditors is underscored by a 60% write-down on a €220 million Schuldscheindarlehen by the Volks- und Raiffeisenbanken, with the association’s president Stefan Müller not ruling out a total loss.

As a backstop to the restructuring, T&G Global remains a key but not definitive lever. BayWa holds roughly 74% of T&G, which posted 2024 revenue of $1.3 billion and delivered a net profit of $16 million. Prospective bidders include private-equity houses focused on agriculture such as Roc Partners, Paine Schwartz, and Hancock. Goldman Sachs entered the process in March 2026. Even at a targeted sale price around €300 million, the deal would fall short of closing BayWa’s €4 billion by 2028 objective. The Hong Kong-based Joy Wing Mau Group, hovering at just under 20% of T&G, continues to slow progress as it weighs its stance.

Compound the financing challenge with the numbers from the prior plan: in the first three-quarters of 2025, revenue fell 22% to €9.6 billion, and the group posted an annual net loss of €1.6 billion. Looking ahead, the group aims to trim roughly 1,300 jobs and steer the business toward an agricultural and building-materials trading focus, projecting turnover of around €10 billion by 2028 from the current €24 billion conglomerate. The group tentatively guides EBITDA for 2027 at roughly €140 million.

Regulatory headwinds add to the pressure. BaFin formally reprimanded BayWa for missing essential details about a €1 billion loan in the 2023 management report, triggering a review by APAS into the long-time auditor PwC, which had issued an unqualified opinion for the period. Against this backdrop, the stock’s vulnerability persists: at €12.95, it sits about 23% below the start of the year and roughly 40% under its 52-week high, with volatility running at an annualized pace near 94%.

A final, defining constraint remains the StaRUG framework. Unless BayWa secures an extension of the standstill arrangement with its banks, the legal basis for the rescue plan could erode by autumn. In that sense, the upcoming Q1 2026 report, the standstill extension, and progress on the T&G sale are all inextricably linked to whether the company can keep the rescue plan intact.

In sum, BayWa’s course now hinges on execution under new governance, the timely delivery of audited numbers, and the ability to convert asset sales into credible liquidity while negotiating creditor concessions. The three newly appointed supervisory magnates bring sharper oversight to the restructuring, but the road to stability remains heavily contingent on meeting the autumn milestones and chiseling away at the debt and asset-sale gaps that define the current crisis.